Searching for COVID-19 Antibodies in Czech Children - A Needle in the Haystack

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F20%3A10418258" target="_blank" >RIV/00216208:11130/20:10418258 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/20:10418258 RIV/00064190:_____/20:N0000026 RIV/00216208:11110/20:10418258 RIV/00064165:_____/20:10418258

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=9yP5sJ9IIN" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=9yP5sJ9IIN</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3389/fped.2020.597736" target="_blank" >10.3389/fped.2020.597736</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Searching for COVID-19 Antibodies in Czech Children - A Needle in the Haystack

Popis výsledku v původním jazyce

During the COVID-19 pandemics of 2020, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), both adults and children were shown to mount a specific antibody response to the virus. As infected children often exhibit mild symptoms or even remain asymptomatic, they are likely to be under tested for the direct presence of the virus. Mapping the SARS-CoV-2 antibodies frequency informs more accurately on the disease prevalence and helps guide the protective and therapeutic strategies. To date, only few seroprevalence studies included children. In the Czech Republic, in April 2020, the overall SARS-CoV-2 seroprevalence was estimated not to exceed 1.3%. In July and August, 2020, we screened 200 children (0-18 years of age), who attended the pediatric department of a large hospital in Prague for various COVID-19-unrelated reasons, for the presence of SARS-CoV-2 antibodies. Zero seropositive subjects were found. Therefore, we hereby report a low (&lt;0.5%) seroprevalence amongst children in Prague, as of August, 2020.

Název v anglickém jazyce

Searching for COVID-19 Antibodies in Czech Children - A Needle in the Haystack

Popis výsledku anglicky

During the COVID-19 pandemics of 2020, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), both adults and children were shown to mount a specific antibody response to the virus. As infected children often exhibit mild symptoms or even remain asymptomatic, they are likely to be under tested for the direct presence of the virus. Mapping the SARS-CoV-2 antibodies frequency informs more accurately on the disease prevalence and helps guide the protective and therapeutic strategies. To date, only few seroprevalence studies included children. In the Czech Republic, in April 2020, the overall SARS-CoV-2 seroprevalence was estimated not to exceed 1.3%. In July and August, 2020, we screened 200 children (0-18 years of age), who attended the pediatric department of a large hospital in Prague for various COVID-19-unrelated reasons, for the presence of SARS-CoV-2 antibodies. Zero seropositive subjects were found. Therefore, we hereby report a low (&lt;0.5%) seroprevalence amongst children in Prague, as of August, 2020.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30209 - Paediatrics

Projekt

<a href="/cs/project/NV18-05-00162" target="_blank" >NV18-05-00162: Moderní přístupy k primárním imunodeficiencím: uplatnění molekulární a funkční diagnostiky v terapii</a><br>

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Frontiers in Pediatrics

ISSN

2296-2360

e-ISSN

—

Svazek periodika

8

Číslo periodika v rámci svazku

November

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

6

Strana od-do

597736

Kód UT WoS článku

000592204600001

EID výsledku v databázi Scopus

2-s2.0-85096780786